Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozik

Showing results (631-640 of 694) with videos related to

Pageof 70
Sort By:
Science (New York, N.Y.)|March 12, 2021
Type III secretion system effectors form robust and flexible intracellular virulence networksDavid Ruano-Gallego, Julia Sanchez-Garrido, Zuzanna Kozik, et al.
Gastroenterology|January 18, 2012
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failureAndreas Kribben, Guido Gerken, Sebastian Haag, et al.
Scientific Reports|July 30, 2025
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomesAgnieszka Giza, Paulina Dumnicka, Elżbieta Kalicińska, et al.
Leukemia & Lymphoma|November 3, 2023
Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study GroupOktawia Sośnia, Katarzyna Pruszczyk, Michał Danecki, et al.
Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
International Journal of Molecular Sciences|August 10, 2024
Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal <i>Faecalibacillus intestinalis</i> and Formic Acid as Commonly Altered in Cancer PatientsMaria Kulecka, Paweł Czarnowski, Aneta Bałabas, et al.
The Lancet. Oncology|March 15, 2021
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 studyJohn Kuruvilla, Radhakrishnan Ramchandren, Armando Santoro, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 5, 2023
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research GroupEwa Paszkiewicz-Kozik, Iwona Hus, Monika Palka, et al.
Bioorganicheskaia Khimiia|August 13, 2008
[A comparative analysis of distribution of glyprolines administered by various routes]I P Ashmarin, K E Baglikova, S E Edeeva, et al.
British Journal of Haematology|February 10, 2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experienceBeata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, et al.
Pageof 70

Showing results (631-640 of 694) with videos related to

Sort By:
Pageof 70
Science (New York, N.Y.)|March 12, 2021
Type III secretion system effectors form robust and flexible intracellular virulence networksDavid Ruano-Gallego, Julia Sanchez-Garrido, Zuzanna Kozik, et al.
Gastroenterology|January 18, 2012
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failureAndreas Kribben, Guido Gerken, Sebastian Haag, et al.
Scientific Reports|July 30, 2025
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomesAgnieszka Giza, Paulina Dumnicka, Elżbieta Kalicińska, et al.
Leukemia & Lymphoma|November 3, 2023
Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study GroupOktawia Sośnia, Katarzyna Pruszczyk, Michał Danecki, et al.
Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
International Journal of Molecular Sciences|August 10, 2024
Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal <i>Faecalibacillus intestinalis</i> and Formic Acid as Commonly Altered in Cancer PatientsMaria Kulecka, Paweł Czarnowski, Aneta Bałabas, et al.
The Lancet. Oncology|March 15, 2021
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 studyJohn Kuruvilla, Radhakrishnan Ramchandren, Armando Santoro, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|January 5, 2023
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research GroupEwa Paszkiewicz-Kozik, Iwona Hus, Monika Palka, et al.
Bioorganicheskaia Khimiia|August 13, 2008
[A comparative analysis of distribution of glyprolines administered by various routes]I P Ashmarin, K E Baglikova, S E Edeeva, et al.
British Journal of Haematology|February 10, 2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experienceBeata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, et al.
Pageof 70